Changes

no edit summary
Line 420: Line 420:  
|[[GTS5:Neurofibromatosis_type_1_(NF1)|Neurofibromatosis type 1 (NF1)]]
 
|[[GTS5:Neurofibromatosis_type_1_(NF1)|Neurofibromatosis type 1 (NF1)]]
 
|Disease
 
|Disease
 +
|Ngoni Faya (trainee) + Madina Sukhanova
 +
|7/12/2023
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|Madina Sukhanova (Madina S)
 
|
 
|
|
+
|Named based on GTS5 book
|
  −
|
  −
|
  −
|
   
|-
 
|-
 
|[[GTS5:NF2-related_schwannomatosis_(NF2)|NF2-related schwannomatosis (NF2)]]
 
|[[GTS5:NF2-related_schwannomatosis_(NF2)|NF2-related schwannomatosis (NF2)]]
Line 497: Line 497:  
|[[GTS5:Familial_adenomatous_polyposis_(APC)|Familial adenomatous polyposis (APC)]]
 
|[[GTS5:Familial_adenomatous_polyposis_(APC)|Familial adenomatous polyposis (APC)]]
 
|Disease
 
|Disease
 +
|Jennifer Laffin
 +
|8/20/2023
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|MS / LS
 
|
 
|
|
+
|Named based on GTS5 book
|
  −
|
  −
|
  −
|
   
|-
 
|-
 
|[[GTS5:Gastric_Adenocarcinoma_and_Proximal_Polyposis_of_Stomach_-_GAPPS_(APC_promoter)|Gastric Adenocarcinoma and Proximal Polyposis of Stomach - GAPPS (APC promoter)]]
 
|[[GTS5:Gastric_Adenocarcinoma_and_Proximal_Polyposis_of_Stomach_-_GAPPS_(APC_promoter)|Gastric Adenocarcinoma and Proximal Polyposis of Stomach - GAPPS (APC promoter)]]
Line 581: Line 581:  
|
 
|
 
|
 
|
|
+
|Named based on GTS5 book (page created 12/30/23)
 
|-
 
|-
 
|[[GTS5:Hereditary_gastric_and_breast_cancer_syndrome_(CDH1,_CTNNA1)|Hereditary gastric and breast cancer syndrome (CDH1, CTNNA1)]]
 
|[[GTS5:Hereditary_gastric_and_breast_cancer_syndrome_(CDH1,_CTNNA1)|Hereditary gastric and breast cancer syndrome (CDH1, CTNNA1)]]
Line 592: Line 592:  
|
 
|
 
|
 
|
|
+
|Named based on GTS5 book (page created 12/30/23)
 
|-
 
|-
 
|[[GTS5:Hereditary_mixed_polyposis_syndrome_(GREM1)|Hereditary mixed polyposis syndrome (GREM1)]]
 
|[[GTS5:Hereditary_mixed_polyposis_syndrome_(GREM1)|Hereditary mixed polyposis syndrome (GREM1)]]
Line 841: Line 841:  
|
 
|
 
|
 
|
|
+
|Named based on GTS5 book (page created 12/30/23)
 
|-
 
|-
 
|[[GTS5:Retinoblastoma_syndrome_(RB1)|Retinoblastoma syndrome (RB1)]]
 
|[[GTS5:Retinoblastoma_syndrome_(RB1)|Retinoblastoma syndrome (RB1)]]
Line 942: Line 942:  
|[[GTS5:Constitutional_mismatch_repair_deficiency_(CMMRD)_syndrome_(MLH1,_PMS2,_MSH2,_MSH6)|Constitutional mismatch repair deficiency (CMMRD) syndrome (MLH1, PMS2, MSH2, MSH6)]]
 
|[[GTS5:Constitutional_mismatch_repair_deficiency_(CMMRD)_syndrome_(MLH1,_PMS2,_MSH2,_MSH6)|Constitutional mismatch repair deficiency (CMMRD) syndrome (MLH1, PMS2, MSH2, MSH6)]]
 
|Disease
 
|Disease
 +
|Jennie Thurston
 +
|7/2/2023
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|LS
 
|
 
|
|
+
|Named based on GTS5 book
|
  −
|
  −
|
  −
|
   
|-
 
|-
 
|[[GTS5:BRCA-related_cancer_predisposition_syndrome_(BRCA1,_BRCA2)|BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)]]
 
|[[GTS5:BRCA-related_cancer_predisposition_syndrome_(BRCA1,_BRCA2)|BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)]]
 
|Disease
 
|Disease
 +
|Constance Albarracin / Katherine Geiersbach
 
|
 
|
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|Katherine Geiersbach
 
|
 
|
|
+
|Named based on GTS5 book (page created 12/30/23)
|
  −
|
  −
|
   
|-
 
|-
 
|[[GTS5:PALB2-related_cancer_predisposition_syndrome_(PALB2)|PALB2-related cancer predisposition syndrome (PALB2)]]
 
|[[GTS5:PALB2-related_cancer_predisposition_syndrome_(PALB2)|PALB2-related cancer predisposition syndrome (PALB2)]]
 
|Disease
 
|Disease
 +
|Constance Albarracin / Katherine Geiersbach / Jun Liao
 
|
 
|
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|Katherine Geiersbach
 
|
 
|
|
+
|Named based on GTS5 book (page created 12/30/23)
|
  −
|
  −
|
   
|-
 
|-
 
|[[GTS5:RAD51-related_cancer_predisposition_syndrome_(RAD51C,_RAD51D)|RAD51-related cancer predisposition syndrome (RAD51C, RAD51D)]]
 
|[[GTS5:RAD51-related_cancer_predisposition_syndrome_(RAD51C,_RAD51D)|RAD51-related cancer predisposition syndrome (RAD51C, RAD51D)]]
Line 1,041: Line 1,041:  
|[[GTS5:Ataxia-telangiectasia_syndrome_(ATM)|Ataxia-telangiectasia syndrome (ATM)]]
 
|[[GTS5:Ataxia-telangiectasia_syndrome_(ATM)|Ataxia-telangiectasia syndrome (ATM)]]
 
|Disease
 
|Disease
 +
|Evin Gulbahce / Katherine Geiersbach
 
|
 
|
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|Katherine Geiersbach
 
|
 
|
|
+
|Named based on GTS5 book (page created 12/30/23)
|
  −
|
  −
|
   
|-
 
|-
 
|[[GTS5:CHEK2-related_hereditary_(breast)_cancer_predisposition_syndrome_(CHEK2)|CHEK2-related hereditary (breast) cancer predisposition syndrome (CHEK2)]]
 
|[[GTS5:CHEK2-related_hereditary_(breast)_cancer_predisposition_syndrome_(CHEK2)|CHEK2-related hereditary (breast) cancer predisposition syndrome (CHEK2)]]
Line 1,059: Line 1,059:  
|
 
|
 
|
 
|
|
+
|Named based on GTS5 book (page created 12/30/23)
 
|-
 
|-
 
|[[GTS5:Nijmegen_breakage_syndrome_(NBN)|Nijmegen breakage syndrome (NBN)]]
 
|[[GTS5:Nijmegen_breakage_syndrome_(NBN)|Nijmegen breakage syndrome (NBN)]]
Line 1,321: Line 1,321:  
|[[GTS5:DICER1-related_tumour_predisposition_syndrome_(DICER1)|DICER1-related tumour predisposition syndrome (DICER1)]]
 
|[[GTS5:DICER1-related_tumour_predisposition_syndrome_(DICER1)|DICER1-related tumour predisposition syndrome (DICER1)]]
 
|Disease
 
|Disease
 +
|Jennie Thurston
 +
|7/2/2023
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|LS
 
|
 
|
|
+
|Named based on GTS5 book
|
  −
|
  −
|
  −
|
   
|-
 
|-
 
|[[GTS5:MicroRNA_processor_tumour_predisposition_syndromes_(DROSHA,_DGCR8)|MicroRNA processor tumour predisposition syndromes (DROSHA, DGCR8)]]
 
|[[GTS5:MicroRNA_processor_tumour_predisposition_syndromes_(DROSHA,_DGCR8)|MicroRNA processor tumour predisposition syndromes (DROSHA, DGCR8)]]